Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study

Eskiizmir G., ÇALIBAŞI KOÇAL G., Uysal T., ELLİDOKUZ H., BAŞBINAR Y.

ENT Updates, cilt.6, sa.3, ss.105-109, 2016 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.2399/jmu.2016003005
  • Dergi Adı: ENT Updates
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.105-109
  • Anahtar Kelimeler: Antitumor, cetuximab, oral cavity, cancer, GROWTH-FACTOR RECEPTOR, TARGETED THERAPY, COMBINATION, CISPLATIN, CARCINOMA, ANTIBODY, NECK, LUNG, HEAD, C225
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: To evaluate the antitumor effect of cetuximab as a single agent for the treatment of oral cavity cancers and to clarify the dose-dependent growth inhibitory effect in oral cavity squamous cell carcinoma cell line (OCSCCCL).